FedEx CorporationNYSE: FDX

IWP Capital to Vote "FOR" FedEx Proposal 6 on Abortion-Drug Distribution Risk

· Issued by FedEx Corporation via PR Newswire

Summary by 6ix AI

IWP Capital, LLC, a faith-based service provider and co-filer of Proposal 6 in the FedEx Corporation 2026 proxy statement, said on September 18, 2026 that it intends to vote FOR the proposal at FedEx's annual meeting on September 28, 2026.

Key details

  • The proposal, Report on Risks Related to Distributing Abortion Drugs, was filed by IWP Capital with the Catholic Diocese of Fort Worth and appears in the Stockholder Proposals section of FedEx's proxy statement, beginning on page 104.
  • The proposal is precatory, meaning advisory and not binding. It asks FedEx's board to report, within one year and at reasonable cost, on how it oversees the legal, regulatory and reputational risks of transporting mail-order abortion drugs such as mifepristone.
  • The proposal does not ask FedEx to stop shipping any lawful product or to inspect packages.
  • IWP Capital encourages other shareholders to review the proposal and consider voting for it. It says it is not soliciting proxies, meaning it is not asking for authority to vote other shareholders' shares, and will return any proxy cards it receives.

What’s still pending

  • The vote on Proposal 6 is scheduled for FedEx's annual meeting on September 28, 2026; the outcome is not yet known.

6ix AI wrote this summary from the release below and checked it against the release.

Co-filer urges a board-level risk report as Comstock Act enforcement remains unsettled ahead of the September 28 annual meeting

FORT WORTH, Texas, Sept. 18, 2026 /PRNewswire/ -- IWP Capital, LLC, a faith-based service provider and co-filer of Proposal 6 on the FedEx Corporation (NYSE: FDX) 2026 proxy statement, today said it intends to vote FOR the proposal at the company's annual meeting on September 28, 2026. The proposal, Report on Risks Related to Distributing Abortion Drugs, was filed by IWP Capital with the Catholic Diocese of Fort Worth and appears in the Stockholder Proposals section of FedEx's proxy statement, beginning on page 104.

The proposal is precatory and procedural. It asks FedEx's board to report, within one year and at reasonable cost, on how it oversees the legal, regulatory, and reputational risks of transporting mail-order abortion drugs such as mifepristone. It does not ask FedEx to stop shipping any lawful product or to inspect packages.

"We are asking a board that emphasizes risk oversight to tell its owners how it is preparing for a criminal statute whose enforcement is genuinely unsettled," said Sam Saladino, Chief Executive Officer of IWP Capital. "Legal uncertainty of this magnitude is itself a material risk. That is why we intend to vote for Proposal 6."

IWP notes the reputational pressure runs both ways — from investors urging continued access and from faith-based coalitions — giving the board a governance reason to document its reasoning. IWP Capital intends to vote FOR Proposal 6 and encourages fellow shareholders to review the proposal and consider doing the same.

IMPORTANT NOTICE

This press release is a public statement by IWP Capital, LLC, a shareholder of FedEx Corporation, of how it intends to vote on Proposal 6 and its reasons for that decision. It is furnished in reliance on Rule 14a-1(l)(2)(iv) under the Securities Exchange Act of 1934 and is not a solicitation of authority to vote any proxy. IWP Capital is NOT asking for, and will NOT accept, proxy cards; any proxy card received will be returned. IWP Capital cannot vote your shares and is not requesting the authority to do so. Shareholders should vote using only the official proxy materials distributed by FedEx.

View original content:https://www.prnewswire.com/news-releases/iwp-capital-to-vote-for-fedex-proposal-6-on-abortion-drug-distribution-risk-302882388.html

SOURCE IWP Capital, LLC

View original source (PR Newswire)FedEx Corporation on 6ix

Earlier from FedEx

Later from FedEx

All FedEx news releases